Thousands of patients will miss out on life-extending drugs after NHS England removed some from the Cancer Drugs Fund. Among the drugs de-listed are those to treat breast cancer, multiple myeloma, bowel cancer, pancreatic cancer, cervical cancer and leukaemia.